Cuba: First stage of phase III trial with Soberana 02 concludes
The study’s principal researcher, Dr. María Eugenia Toledo, stated that so far the results of the process are “encouraging in terms of the safety of the product and the immune response.”
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed